Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2020

01-12-2020 | Sarcoma | Primary research

Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma

Authors: Naiqiang Zhu, Jingyi Hou

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Abstract

Background

Sarcomas, cancers originating from mesenchymal cells, are comprehensive tumors with poor prognoses, yet their tumorigenic mechanisms are largely unknown. In this study, we characterize infiltrating immune cells and analyze immune scores to identify the molecular mechanism of immunologic response to sarcomas.

Method

The “CIBERSORT” algorithm was used to calculate the amount of L22 immune cell infiltration in sarcomas. Then, the “ESTIMATE” algorithm was used to assess the “Estimate,” “Immune,” and “Stromal” scores. Weighted gene co-expression network analysis (WGCNA) was utilized to identify the significant module related to the immune therapeutic target. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the “clusterProfiler” package in R for annotation and visualization.

Results

Macrophages were the most common immune cells infiltrating sarcomas. The number of CD8 T cells was negatively associated with that of M0 and M2 macrophages, and positively associated with M macrophages in sarcomas samples. The clinical parameters (disease type, gender) significantly increased with higher Estimate, Immune, and Stromal scores, and with a better prognosis. The blue module was significantly associated with CD8 T cells. Functional enrichment analysis showed that the blue module was mainly involved in chemokine signaling and the PI3K-Akt signaling pathway. CD48, P2RY10 and RASAL3 were identified and validated at the protein level.

Conclusion

Based on the immune cell infiltration and immune microenvironment, three key genes were identified, thus presenting novel molecular mechanisms of sarcoma metastasis.
Appendix
Available only for authorised users
Literature
1.
Hornick JL. Subclassification of pleomorphic sarcomas: how and why should we care? Ann Diagn Pathol. 2018;37:118–24.CrossRefPubMed
2.
Ferrari A, Dirksen U, Bielack S. Sarcomas of soft tissue and bone. Prog Tumor Res. 2016;43:128–41.CrossRefPubMed
3.
Hatina J, Kripnerova M, Houfkova K, Pesta M, Kuncova J, Sana J, Slaby O, Rodriguez R. Sarcoma stem cell heterogeneity. Adv Exp Med Biol. 2019;1123:95–118.CrossRefPubMed
4.
Paumard-Hernandez B, Calvete O, Inglada Perez L, Tejero H, Al-Shahrour F, Pita G, Barroso A, Carlos Trivino J, Urioste M, Valverde C, et al. Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer. Int J Cancer. 2018;143(8):1954–62.CrossRefPubMed
5.
Golas G, Jang SJ, Naik NG, Alonso JD, Papp B, Toth Z. Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway. Virology. 2020;541:160–73.CrossRefPubMed
6.
Cheng Y, Yu C, Zhu S, Guo L, Zhang Y, Zhang Y, Ma X. Nonleukemic granulocytic sarcoma of orbit after blunt trauma: a case report and review of literature. Medicine (Baltimore). 2018;97(15):e0373.CrossRef
7.
Buchta CM, Boi SK, Miller BJ, Milhem MM, Norian LA. Obesity does not exacerbate the protumorigenic systemic environment in sarcoma subjects. Immunohorizons. 2017;1(4):20–8.CrossRefPubMedPubMedCentral
8.
9.
McEvoy CR, Fox SB, Prall OWJ. Emerging entities in NUTM1-rearranged neoplasms. Genes Chromosomes Cancer. 2020;59(6):375–85.CrossRefPubMed
10.
Soyfer V, Corn BW, Shtraus N, Honig N, Meir Y, Kollender J, Merimsky O. Single-institution experience of SBRT for lung metastases in sarcoma patients. Am J Clin Oncol. 2017;40(1):83–5.CrossRefPubMed
11.
Stevenson JD, Doxey R, Abudu A, Parry M, Evans S, Peart F, Jeys L. Vascularized fibular epiphyseal transfer for proximal humeral reconstruction in children with a primary sarcoma of bone. Bone Joint J. 2018;100–B(4):535–41.CrossRefPubMed
12.
Requena C, Alsina M, Morgado-Carrasco D, Cruz J, Sanmartin O, Serra-Guillen C, Llombart B. Kaposi sarcoma and cutaneous angiosarcoma: guidelines for diagnosis and treatment. Actas Dermosifiliogr. 2018;109(10):878–87.CrossRefPubMed
13.
Ghirardi V, Bizzarri N, Guida F, Vascone C, Costantini B, Scambia G, Fagotti A. Role of surgery in gynaecological sarcomas. Oncotarget. 2019;10(26):2561–75.CrossRefPubMedPubMedCentral
14.
Porpiglia AS, Reddy SS, Farma JM. Retroperitoneal Sarcomas. Surg Clin North Am. 2016;96(5):993–1001.CrossRefPubMed
15.
16.
Shitara K, Ueha S, Shichino S, Aoki H, Ogiwara H, Nakatsura T, Suzuki T, Shimomura M, Yoshikawa T, Shoda K, et al. First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors. J Immunother Cancer. 2019;7(1):195.CrossRefPubMedPubMedCentral
17.
Tagliabue L, Capozza A, Maioli C, Luciani A, Ierardi AM, Carrafiello G. Immunotherapy treatment: an issue for metabolic response. Q J Nucl Med Mol Imaging. 2018;62(2):140–51.PubMed
18.
Pandolfi F, Franza L, Todi L, Carusi V, Centrone M, Buonomo A, Chini R, Newton EE, Schiavino D, Nucera E. The importance of complying with vaccination protocols in developed countries: “Anti-Vax” hysteria and the spread of severe preventable diseases. Curr Med Chem. 2018;25(42):6070–81.CrossRefPubMed
19.
20.
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.CrossRefPubMedPubMedCentral
21.
Chen J, Wang X, Hu B, He Y, Qian X, Wang W. Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network. PeerJ. 2018;6:e4692.CrossRefPubMedPubMedCentral
22.
Murray NP, Fuentealba C, Salazar A, Reyes E. Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy. Turk J Urol. 2020;46(2):115–22.CrossRefPubMedPubMedCentral
23.
Ciardullo S, Muraca E, Perra S, Bianconi E, Zerbini F, Oltolini A, Cannistraci R, Parmeggiani P, Manzoni G, Gastaldelli A, et al. Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ Open Diabetes Res Care. 2020;8(1):e000904.CrossRefPubMedPubMedCentral
24.
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.CrossRefPubMedPubMedCentral
25.
26.
27.
Pei G, Chen L, Zhang W. WGCNA application to proteomic and metabolomic data analysis. Methods Enzymol. 2017;585:135–58.CrossRefPubMed
28.
Luo Y, Shen D, Chen L, Wang G, Liu X, Qian K, Xiao Y, Wang X, Ju L. Identification of 9 key genes and small molecule drugs in clear cell renal cell carcinoma. Aging (Albany NY). 2019;11(16):6029–52.CrossRef
29.
Wang J, Tian GG, Zheng Z, Li B, Xing Q, Wu J. Comprehensive transcriptomic analysis of mouse gonadal development involving sexual differentiation meiosis and gametogenesis. Biol Proced Online. 2019;21:20.CrossRefPubMedPubMedCentral
30.
Li W, Liu J, Zhao H. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Aging (Albany NY). 2020;12(2):1512–26.CrossRef
31.
32.
Hunstad JP, Daniels MA, Crantford JC. Autologous flap gluteal augmentation: purse-string technique. Clin Plast Surg. 2018;45(2):261–7.CrossRefPubMed
33.
Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.CrossRefPubMed
34.
Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–4.CrossRefPubMed
35.
Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):l1.CrossRef
36.
Zhao Z, Wang Y. Comment on: gene expression profiles for a prognostic immunoscore in gastric cancer. Br J Surg. 2019;106(10):1416.CrossRefPubMed
37.
Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie H, Fu Q, Dai B, Ye D, Xu J. Identification and validation of stromal immunotype predict survival and benefit from adjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin Cancer Res. 2018;24(13):3069–78.CrossRefPubMed
38.
Varol C, Mildner A, Jung S. Macrophages: development and tissue specialization. Annu Rev Immunol. 2015;33:643–75.CrossRefPubMed
39.
Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399–416.CrossRefPubMedPubMedCentral
40.
Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17(12):887–904.CrossRefPubMed
41.
Yamaguchi T, Movila A, Kataoka S, Wisitrasameewong W, Ruiz Torruella M, Murakoshi M, Murakami S, Kawai T. Proinflammatory M1 macrophages inhibit RANKL-induced osteoclastogenesis. Infect Immun. 2016;84(10):2802–12.CrossRefPubMedPubMedCentral
42.
Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15:577.CrossRefPubMedPubMedCentral
43.
Duhen T, Duhen R, Montler R, Moses J, Moudgil T, de Miranda NF, Goodall CP, Blair TC, Fox BA, McDermott JE, et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat Commun. 2018;9(1):2724.CrossRefPubMedPubMedCentral
44.
D’Angelo SP, Shoushtari AN, Agaram NP, Kuk D, Qin LX, Carvajal RD, Dickson MA, Gounder M, Keohan ML, Schwartz GK, et al. Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Hum Pathol. 2015;46(3):357–65.CrossRefPubMed
45.
Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544–8.CrossRefPubMedPubMedCentral
46.
Frantsiants EM, Kaplieva IV, Trepitaki LK, Karnaukhov NS, Kotieva IM. Method for stimulation of malignant growth by chronic pain in rat lungs. Bull Exp Biol Med. 2020;169(2):290–2.CrossRefPubMed
47.
Lidenge SJ, Tso FY, Ngalamika O, Kolape J, Ngowi JR, Mwaiselage J, Wood C, West JT. Lack of CD8(+) T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors. Oncotarget. 2020;11(17):1556–72.CrossRefPubMedPubMedCentral
48.
Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147.PubMedPubMedCentral
49.
50.
51.
Shi Y, Zhu S, Yang J, Shao M, Ding W, Jiang W, Sun X, Yao N. Investigation of potential mechanisms associated with non-small cell lung cancer. J Comput Biol. 2020;27(9):1433–42.CrossRefPubMed
52.
Liang JW, Fang ZY, Huang Y, Liuyang ZY, Zhang XL, Wang JL, Wei H, Wang JZ, Wang XC, Zeng J, et al. Application of weighted gene co-expression network analysis to explore the key genes in Alzheimer’s Disease. J Alzheimers Dis. 2018;65(4):1353–64.CrossRefPubMedPubMedCentral
53.
Zhu N, Zhang P, Du L, Hou J, Xu B. Identification of key genes and expression profiles in osteoarthritis by co-expressed network analysis. Comput Biol Chem. 2020;85:107225.CrossRefPubMed
54.
Rutkowski P, Kaminska J, Kowalska M, Ruka W, Steffen J. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis. J Surg Oncol. 2003;84(3):151–9.CrossRefPubMed
55.
Gustavsson M. New insights into the structure and function of chemokine receptor:chemokine complexes from an experimental perspective. J Leukoc Biol. 2020;107(6):1115–22.CrossRefPubMed
56.
Kahn J, Deverapalli SC, Rosmarin D. JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases. Semin Cutan Med Surg. 2018;37(3):198–208.CrossRefPubMed
57.
Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017;15(1):23.CrossRefPubMedPubMedCentral
58.
Liu Q, Li Z, Shang H, Zhang Q, Wang X, Zhang Y, Wang Y, Li Q, Li C, Liu C, et al. Scavenger receptor class B type 1 (SR-B1) being a potential biomarker for the diagnosis of liposarcoma and associated with the degree of differentiation of liposarcomas. J Cancer. 2019;10(18):4326–32.CrossRefPubMedPubMedCentral
59.
Ishida Y. Fine structure of primary reticulum cell sacroma of the brain. Acta Neuropathol Suppl. 1975;6:147–53.PubMed
60.
Avnet S, Lemma S, Cortini M, Pellegrini P, Perut F, Zini N, Kusuzaki K, Chano T, Grisendi G, Dominici M, et al. Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance. Oncotarget. 2016;7(39):63408–23.CrossRefPubMedPubMedCentral
61.
Yoshida A, Wakai S, Ryo E, Miyata K, Miyazawa M, Yoshida KI, Motoi T, Ogawa C, Iwata S, Kobayashi E, et al. Expanding the phenotypic spectrum of mesenchymal tumors harboring the EWSR1-CREM fusion. Am J Surg Pathol. 2019;43(12):1622–30.PubMedCrossRef
62.
Wang Z, Xiao Y, Guan W, Wang M, Chen J, Zhang L, Li Y, Xiong Q, Wang H, Wang M, et al. Acute myeloid leukemia immune escape by epigenetic CD48 silencing. Clin Sci (Lond). 2020;134(2):261–71.CrossRef
63.
Liu J, Hettmer S, Milsom MD, Hofmann I, Hua F, Miller C, Bronson RT, Wagers AJ. Induction of histiocytic sarcoma in mouse skeletal muscle. PLoS ONE. 2012;7(8):e44044.CrossRefPubMedPubMedCentral
64.
Qin Y, Verdegaal EM, Siderius M, Bebelman JP, Smit MJ, Leurs R, Willemze R, Tensen CP, Osanto S. Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell Melanoma Res. 2011;24(1):207–18.CrossRefPubMed
65.
Wang LX, Li Y, Chen GZ. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma. PLoS ONE. 2018;13(1):e0190447.CrossRefPubMedPubMedCentral
66.
Muro R, Nitta T, Okada T, Ideta H, Tsubata T, Suzuki H. The Ras GTPase-activating protein Rasal3 supports survival of naive T cells. PLoS ONE. 2015;10(3):e0119898.CrossRefPubMedPubMedCentral
67.
Saito S, Kawamura T, Higuchi M, Kobayashi T, Yoshita-Takahashi M, Yamazaki M, Abe M, Sakimura K, Kanda Y, Kawamura H, et al. RASAL3, a novel hematopoietic RasGAP protein, regulates the number and functions of NKT cells. Eur J Immunol. 2015;45(5):1512–23.CrossRefPubMed
68.
Qi Y, Wang N, Pang LJ, Zou H, Hu JM, Zhao J, Zhang J, Liu CX, Zhang WJ, Yuan XL, et al. Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip. BMC Med Genomics. 2015;8:69.CrossRefPubMedPubMedCentral
Metadata
Title
Assessing immune infiltration and the tumor microenvironment for the diagnosis and prognosis of sarcoma
Authors
Naiqiang Zhu
Jingyi Hou
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Sarcoma
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01672-3

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue

Primary research

LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2)

Primary research

Lattice complex assembled by noncompetitive anti-EGFR antibodies regulates actin cytoskeletal reorganization

Primary research

CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis

Primary research

EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer

Primary research

LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway

Review

Recent insights into eukaryotic translation initiation factors 5A1 and 5A2 and their roles in human health and disease
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits